Intracellular Th Stock Analysis

Intracellular Stock Analysis Notes

About 97.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.72. Intracellular Th had not issued any dividends in recent years. Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York. Intra-Cellular Ther operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 512 people. To learn more about Intracellular Th call Sharon Mates at 646 440 9333 or check out https://www.intracellulartherapies.com.

Intracellular Th Investment Alerts

Intracellular Th Upcoming and Recent Events

Intracellular Largest EPS Surprises

View All Earnings Estimates

Intracellular Environmental, Social, and Governance (ESG) Scores

Intracellular Stock Institutional Investors

Note, although Intracellular's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Intracellular Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 14.02 B.

Intracellular Profitablity

The company has Profit Margin (PM) of (0.11) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.15) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.15.

Management Efficiency

Intracellular Th has return on total asset (ROA) of (0.0696) % which means that it has lost $0.0696 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0858) %, meaning that it created substantial loss on money invested by shareholders. Intracellular's management efficiency ratios could be used to measure how well Intracellular manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.06. The current Return On Capital Employed is estimated to decrease to -0.11. As of now, Intracellular's Non Current Assets Total are increasing as compared to previous years. The Intracellular's current Non Currrent Assets Other is estimated to increase to about 46.9 M, while Other Assets are projected to decrease to under 94 K.

Technical Drivers

As of the 23rd of March, Intracellular retains the Coefficient Of Variation of 585.47, risk adjusted performance of 0.1595, and Market Risk Adjusted Performance of (7.95). Intracellular technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Intracellular Th Price Movement Analysis

Intracellular Th Insider Trading Activities

Intracellular Outstanding Bonds

Intracellular Predictive Daily Indicators

Intracellular Corporate Filings

Intracellular Forecast Models

Intracellular's time-series forecasting models are one of many Intracellular's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Intracellular's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Intracellular prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Intracellular shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Intracellular. By using and applying Intracellular Stock analysis, traders can create a robust methodology for identifying Intracellular entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Intracellular analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Intracellular analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Intracellular Th stock analysis indicators help investors evaluate how Intracellular stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Intracellular shares will generate the highest return on investment. By understating and applying Intracellular stock analysis, traders can identify Intracellular position entry and exit signals to maximize returns.

When running Intracellular's price analysis, check to measure Intracellular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intracellular is operating at the current time. Most of Intracellular's value examination focuses on studying past and present price action to predict the probability of Intracellular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intracellular's price. Additionally, you may evaluate how the addition of Intracellular to your portfolios can decrease your overall portfolio volatility.